Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Protein kinase C δ signaling is required for dietary prebiotic-induced strengthening of intestinal epithelial barrier function.

Wu RY, Abdullah M, Määttänen P, Pilar AV, Scruten E, Johnson-Henry KC, Napper S, O'Brien C, Jones NL, Sherman PM.

Sci Rep. 2017 Jan 18;7:40820. doi: 10.1038/srep40820.

2.

Protein Kinase C δ: a Gatekeeper of Immune Homeostasis.

Salzer E, Santos-Valente E, Keller B, Warnatz K, Boztug K.

J Clin Immunol. 2016 Oct;36(7):631-40. doi: 10.1007/s10875-016-0323-0. Epub 2016 Aug 19. Review.

3.

Role of PKCδ in Enhanced Expression of Gqα/PLCβ1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats.

Atef ME, Anand-Srivastava MB.

PLoS One. 2016 Jul 5;11(7):e0157955. doi: 10.1371/journal.pone.0157955. eCollection 2016 Jul 5.

4.

Selective Phosphorylation Inhibitor of Delta Protein Kinase C-Pyruvate Dehydrogenase Kinase Protein-Protein Interactions: Application for Myocardial Injury in Vivo.

Qvit N, Disatnik MH, Sho E, Mochly-Rosen D.

J Am Chem Soc. 2016 Jun 22;138(24):7626-35. doi: 10.1021/jacs.6b02724. Epub 2016 Jun 8.

5.

Molecular characterization of protein kinase C delta (PKCδ)-Smac interactions.

Holmgren C, Cornmark L, Lønne GK, Masoumi KC, Larsson C.

BMC Biochem. 2016 May 23;17(1):11. doi: 10.1186/s12858-016-0065-x.

6.

Revealing the acute asthma ignorome: characterization and validation of uninvestigated gene networks.

Riba M, Garcia Manteiga JM, Bošnjak B, Cittaro D, Mikolka P, Le C, Epstein MM, Stupka E.

Sci Rep. 2016 Apr 21;6:24647. doi: 10.1038/srep24647.

7.

Human thrombopoiesis depends on Protein kinase Cδ/protein kinase Cε functional couple.

Carubbi C, Masselli E, Martini S, Galli D, Aversa F, Mirandola P, Italiano JE Jr, Gobbi G, Vitale M.

Haematologica. 2016 Jul;101(7):812-20. doi: 10.3324/haematol.2015.137984. Epub 2016 Apr 14.

8.

Docosahexaenoic acid inhibits 12-O-tetradecanoylphorbol-13- acetate-induced fascin-1-dependent breast cancer cell migration by suppressing the PKCδ- and Wnt-1/β-catenin-mediated pathways.

Lii CK, Chang JW, Chen JJ, Chen HW, Liu KL, Yeh SL, Wang TS, Liu SH, Tsai CH, Li CC.

Oncotarget. 2016 May 3;7(18):25162-79. doi: 10.18632/oncotarget.7301.

9.

Immunogenetics of systemic lupus erythematosus: A comprehensive review.

Ghodke-Puranik Y, Niewold TB.

J Autoimmun. 2015 Nov;64:125-36. doi: 10.1016/j.jaut.2015.08.004. Epub 2015 Aug 29. Review.

10.

Biodistribution and Efficacy of Targeted Pulmonary Delivery of a Protein Kinase C-δ Inhibitory Peptide: Impact on Indirect Lung Injury.

Mondrinos MJ, Knight LC, Kennedy PA, Wu J, Kauffman M, Baker ST, Wolfson MR, Kilpatrick LE.

J Pharmacol Exp Ther. 2015 Oct;355(1):86-98. doi: 10.1124/jpet.115.224832. Epub 2015 Aug 4.

11.

Fyn Kinase Regulates Microglial Neuroinflammatory Responses in Cell Culture and Animal Models of Parkinson's Disease.

Panicker N, Saminathan H, Jin H, Neal M, Harischandra DS, Gordon R, Kanthasamy K, Lawana V, Sarkar S, Luo J, Anantharam V, Kanthasamy AG, Kanthasamy A.

J Neurosci. 2015 Jul 8;35(27):10058-77. doi: 10.1523/JNEUROSCI.0302-15.2015.

12.

Biliverdin reductase: a target for cancer therapy?

Gibbs PE, Miralem T, Maines MD.

Front Pharmacol. 2015 Jun 3;6:119. doi: 10.3389/fphar.2015.00119. eCollection 2015 Jun 3. Review.

13.

BAG3: a new player in the heart failure paradigm.

Knezevic T, Myers VD, Gordon J, Tilley DG, Sharp TE 3rd, Wang J, Khalili K, Cheung JY, Feldman AM.

Heart Fail Rev. 2015 Jul;20(4):423-34. doi: 10.1007/s10741-015-9487-6. Review.

14.

Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway.

Lai KY, Chou YC, Lin JH, Liu Y, Lin KM, Doong SL, Chen MR, Yeh TH, Lin SJ, Tsai CH.

J Virol. 2015 Jun;89(11):5968-80. doi: 10.1128/JVI.00168-15. Epub 2015 Mar 25.

15.

Digging deep into "dirty" drugs - modulation of the methylation machinery.

Pleyer L, Greil R.

Drug Metab Rev. 2015 May;47(2):252-79. doi: 10.3109/03602532.2014.995379. Epub 2015 Jan 8. Review.

16.

The many hats of protein kinase Cδ: one enzyme with many functions.

Qvit N, Mochly-Rosen D.

Biochem Soc Trans. 2014 Dec;42(6):1529-33. doi: 10.1042/BST20140189.

17.

Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.

Bruntz RC, Lindsley CW, Brown HA.

Pharmacol Rev. 2014 Oct;66(4):1033-79. doi: 10.1124/pr.114.009217. Review.

18.

Protein kinase C in the wood frog, Rana sylvatica: reassessing the tissue-specific regulation of PKC isozymes during freezing.

Dieni CA, Storey KB.

PeerJ. 2014 Sep 4;2:e558. doi: 10.7717/peerj.558. eCollection 2014 Sep 4.

19.

Emodin inhibits tonic tension through suppressing PKCδ-mediated inhibition of myosin phosphatase in rat isolated thoracic aorta.

Lim KM, Kwon JH, Kim K, Noh JY, Kang S, Park JM, Lee MY, Bae ON, Chung JH.

Br J Pharmacol. 2014 Sep;171(18):4300-10. doi: 10.1111/bph.12804.

20.

Molecular systems pharmacology: isoelectric focusing signature of protein kinase Cδ provides an integrated measure of its modulation in response to ligands.

Kedei N, Chen JQ, Herrmann MA, Telek A, Goldsmith PK, Petersen ME, Keck GE, Blumberg PM.

J Med Chem. 2014 Jun 26;57(12):5356-69. doi: 10.1021/jm500417b. Epub 2014 Jun 6.

Supplemental Content

Support Center